Option Care Health, Inc. (NASDAQ:OPCH) Receives $31.25 Average PT from Brokerages

Posted by Stanley Muller on May 13th, 2026

Shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) have received an average recommendation of “Moderate Buy” from the twelve brokerages that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $31.25.

Several research firms recently weighed in on OPCH. Barrington Research cut their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a report on Friday, May 1st. TD Cowen cut their target price on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a report on Friday, May 1st. National Bank Financial set a $37.00 target price on Option Care Health in a report on Tuesday, January 27th. Wall Street Zen downgraded Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $26.00 target price on shares of Option Care Health in a report on Friday, May 1st.

Get Our Latest Research Report on Option Care Health

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the business’s stock in a transaction on Monday, May 4th. The shares were purchased at an average cost of $21.41 per share, with a total value of $783,820.10. Following the acquisition, the director owned 450,000 shares of the company’s stock, valued at $9,634,500. This represents a 8.86% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO John Charles Rademacher bought 12,500 shares of the business’s stock in a transaction on Monday, May 4th. The shares were bought at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the acquisition, the chief executive officer directly owned 695,152 shares in the company, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders have purchased 73,264 shares of company stock valued at $1,548,316. 1.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in OPCH. Durable Capital Partners LP raised its position in shares of Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after acquiring an additional 4,720,988 shares in the last quarter. Southpoint Capital Advisors LP bought a new position in shares of Option Care Health in the 4th quarter worth about $95,580,000. Sumitomo Mitsui Trust Group Inc. bought a new position in shares of Option Care Health in the 1st quarter worth about $70,287,000. Norges Bank bought a new position in shares of Option Care Health in the 4th quarter worth about $61,787,000. Finally, Van Berkom & Associates Inc. bought a new position in shares of Option Care Health in the 1st quarter worth about $42,739,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Trading Down 1.2%

NASDAQ OPCH opened at $19.59 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. Option Care Health has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a market cap of $3.08 billion, a price-to-earnings ratio of 15.19, a price-to-earnings-growth ratio of 1.10 and a beta of 0.68. The business’s fifty day moving average is $27.52 and its 200 day moving average is $30.43.

Option Care Health (NASDAQ:OPCH – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. During the same quarter last year, the business posted $0.40 EPS. Option Care Health’s revenue for the quarter was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, sell-side analysts expect that Option Care Health will post 1.64 EPS for the current fiscal year.

About Option Care Health

(Get Free Report)

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.